Skip to main content

Amedisys Value Stock - Dividend - Research Selection

Amedisys

ISIN: US0234361089 , WKN: 915582

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks. The Hospice segment offers care that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer\'s, HIV/AIDS, and cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 27, 2018, the company owned and operated 421 care centers in 34 states. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


UnitedHealth's Push Into Home Health: A New Growth Chapter?

2025-08-20
UNH is expanding further into home health with Optum, fueled by a $3.3B Amedisys deal to boost value-based care growth.

Why Is Twilio (TWLO) Stock Rocketing Higher Today

2025-08-15
Shares of cloud communications infrastructure company Twilio (NYSE:TWLO) jumped 6.5% in the afternoon session after the company was added to the S&P MidCap 400 index. S&P Dow Jones Indices announced that the cloud communications provider will join the index effective prior to the opening of trading on Tuesday, August 19. This inclusion is significant as it typically boosts demand for a company's stock from index funds and other institutional investors that track the benchmark. The move follows t

Why Is UnitedHealth (UNH) Stock Soaring Today

2025-08-15
Shares of health insurance company UnitedHealth (NYSE:UNH) jumped 11.6% in the morning session after the company disclosed that Warren Buffett's Berkshire Hathaway had acquired a significant new stake, with news that regulators had also approved a major merger.

Why Is UnitedHealth Stock Trading Higher Friday?

2025-08-15
UnitedHealth Group Inc. (NYSE:UNH) shares climbed Friday after high-profile investors Michael Burry and Warren Buffett took positions in the insurance giant, offering some relief to a stock that has tumbled about 41% year-to-date. Warren Buffett’s fund bought little more than 5 million shares, and Burry disclosed in 13F filings that he purchased call contracts against 350,000 shares of UnitedHealth. The holdings suggest Burry is betting on a sector turnaround, particularly as Medicare Advantage

UnitedHealth closes $3.3B Amedisys buy after long regulatory battle

2025-08-15
UnitedHealth, Amedisys and the DOJ reached a settlement last week, clearing the way for the deal to be finalized. Amedisys stopped trading on Nasdaq Thursday.

UnitedHealth-Amedisys Merger Cleared After DOJ Settlement and Divestiture

2025-08-15
UnitedHealth Group Incorporated (NYSE:UNH) is one of the best high-volume stocks to invest in. On August 7, UnitedHealth and Amedisys Inc. (NASDAQ:AMED) reached a settlement with the Department of Justice/DOJ and 4 states, clearing the way for their $3.3 billion merger. The settlement, which was filed in a Maryland district court, addresses antitrust concerns raised […]

Twilio Set to Join S&P MidCap 400

2025-08-14
Twilio Inc. (NYSE: TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE: UNH) acquired Amedisys in a deal completed today.

Can UnitedHealth Really Fight Cost Headaches With $3.3B Amedisys Pill?

2025-08-12
UNH's $3.3B Amedisys deal will likely clear DOJ hurdles with divestitures, aiming to tap fast-growing home healthcare amid rising cost pressures.

UnitedHealth’s $3.3bn Amedisys deal faces strict divestiture terms

2025-08-11
UnitedHealth faced legal challenges last year when the US Justice Department and state attorneys general moved to block the acquisition.

UnitedHealth, Amedisys merger appears set to close post-DOJ settlement

2025-08-08
Thursday’s settlement is weaker than at least one antitrust expert expected based on the severity of the DOJ’s concerns. But it means the $3.3 billion merger is very likely to close next year.